Probiotic supplements might not be universally-effective and safe: A review

Biomedicine and Pharmacotherapy

Volumn 111, Issue , 2019, Pages 537-547

  Kothari, Damini ^a   Patel, Seema ^b   Kim, Soo Ki ^a  

^a Konkuk University   (South Korea)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Adverse effects; Allergy; At risk population; Compromised gut; Dietary supplements; Immunomodulation; Probiotics; Sepsis

Indexed keywords

PROBIOTIC AGENT;

ALLERGIC REACTION; ANTIBIOTIC RESISTANCE; BACTERIAL ENDOCARDITIS; DIETARY SUPPLEMENT; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFECTION; ISCHEMIA; METABOLIC DISORDER; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; SEPSIS; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECT; DYSBIOSIS; INTESTINE FLORA; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; DIETARY SUPPLEMENTS; DYSBIOSIS; ENDOCARDITIS, BACTERIAL; GASTROINTESTINAL MICROBIOME; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; SYSTEMATIC REVIEWS AS TOPIC;

EID: 85059112732     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2018.12.104     Document Type: Review

References (131)

1. Gerritsen, J., Smidt, H., Rijkers, G.T., de Vos, W.M., Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 6 (2011), 209–240, 10.1007/s12263-011-0229-7.
2. Swain, M.R., Anandharaj, M., Ray, R.C., Parveen Rani, R., Fermented fruits and vegetables of Asia: a potential source of probiotics. Biotechnol. Res. Int.(2014), 2014, 250424, 10.1155/2014/250424.
3. Chilton, S.N., Burton, J.P., Reid, G., Inclusion of fermented foods in food guides around the world. Nutrients. 7 (2015), 390–404, 10.3390/nu7010390.
4. Galland, L., The gut microbiome and the brain. J. Med. Food 17 (2014), 1261–1272, 10.1089/jmf.2014.7000.
5. Fijan, S., Microorganisms with claimed probiotic properties: an overview of recent literature. Int. J. Environ. Res. Public Health 11 (2014), 4745–4767, 10.3390/ijerph110504745.
6. Carabotti, M., Scirocco, A., Maselli, M.A., Severi, C., The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. Q. Publ. Hell. Soc. Gastroenterol. 28 (2015), 203–209 (Accessed June 9 2015) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4367209&tool=pmcentrez&rendertype=abstract.
7. Haukioja, A., Probiotics and oral health. Eur. J. Dent. 4 (2010), 348–355 (Accessed September 11 2015) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2897872&tool=pmcentrez&rendertype=abstract.
8. Kandwal, A., Chatterjee, A., Bhattacharya, H., Probiotics in periodontal health and disease. J. Indian Soc. Periodontol., 15, 2011, 23, 10.4103/0972-124X.82260.
9. Collado, M.C., Isolauri, E., Salminen, S., Sanz, Y., The impact of probiotic on gut health. Curr. Drug Metab. 10 (2009), 68–78 (Accessed October 12 2015) http://www.ncbi.nlm.nih.gov/pubmed/19149514.
10. Aragon, G., Graham, D.B., Borum, M., Doman, D.B., Probiotic therapy for irritable bowel syndrome. Gastroenterol. Hepatol. (N.Y.) 6 (2010), 39–44 (Accessed July 31 2015) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2886445&tool=pmcentrez&rendertype=abstract.
11. Patel, S., Shukla, R., Goyal, A., Probiotics in valorization of innate immunity across various animal models. J. Funct. Foods 14 (2015), 549–561, 10.1016/j.jff.2015.02.022.
12. Thushara, R.M., Gangadaran, S., Solati, Z., Moghadasian, M.H., Cardiovascular benefits of probiotics: a review of experimental and clinical studies. Food Funct. 7 (2016), 632–642, 10.1039/c5fo01190f.
13. Nouri, Z., Karami, F., Neyazi, N., Modarressi, M.H., Karimi, R., Khorramizadeh, M.R., Taheri, B., Motevaseli, E., Dual anti-metastatic and anti-proliferative activity assessment of two probiotics on HeLa and HT-29 cell lines. Cell J. 18 (2016), 127–134.
14. Huang, R., Wang, K., Hu, J., Effect of Probiotics on Depression: a systematic review and meta-analysis of randomized controlled trials. Nutrients, 8, 2016, 10.3390/nu8080483.
15. Yang, H., Zhao, X., Tang, S., Huang, H., Zhao, X., Ning, Z., Fu, X., Zhang, C., Probiotics reduce psychological stress in patients before laryngeal cancer surgery. Asia. J. Clin. Oncol. 12 (2016), e92–e96, 10.1111/ajco.12120.
16. Kasińska, M.A., Drzewoski, J., Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Pol. Arch. Med. Wewn. 125 (2015), 803–813, 10.20452/pamw.3156.
17. Prados-Bo, A., Gómez-Martínez, S., Nova, E., Marcos, A., Role of probiotics in obesity management. Nutr. Hosp. 31:Suppl. 1 (2015), 10–18, 10.3305/nh.2015.31.sup1.8702.
18. Wischmeyer, P.E., McDonald, D., Knight, R., Role of the microbiome, probiotics, and “dysbiosis therapy” in critical illness. Curr. Opin. Crit. Care 22 (2016), 347–353, 10.1097/MCC.0000000000000321.
19. U.S. Food and Drug Administration, Dietary Supplement Health and Education Act of 1994. 1994, US Dep. Heal. Hum. Serv.
20. Hammerman, C., Bin-Nun, A., Kaplan, M., Safety of probiotics: comparison of two popular strains. BMJ. 333 (2006), 1006–1008, 10.1136/bmj.39010.630799.BE.
21. Sanders, M.E., Akkermans, L.M.A., Haller, D., Hammerman, C., Heimbach, J., Hörmannsperger, G., Huys, G., Levy, D.D., Lutgendorff, F., Mack, D., Phothirath, P., Solano-Aguilar, G., Vaughan, E., Safety assessment of probiotics for human use. Gut Microbes 1 (2010), 164–185, 10.4161/gmic.1.3.12127.
22. van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F., Brummer, R.J., Probiotic and synbiotic safety in infants under two years of age. Benef. Microbes 5 (2014), 45–60, 10.3920/BM2013.0046.
23. Kochan, P., Chmielarczyk, A., Szymaniak, L., Brykczynski, M., Galant, K., Zych, A., Pakosz, K., Giedrys-Kalemba, S., Lenouvel, E., Heczko, P.B., Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient-is the time right to revise probiotic safety guidelines?. Clin. Microbiol. Infect. 17 (2011), 1589–1592, 10.1111/j.1469-0691.2011.03614.x.
24. Martín Muñoz, M., Caballero, T., Caminoa, M., Belver, M., Rojas, E., Quirce, S., Allergy to a probiotic compound. Allergy Eur. J. Allergy Clin. Immunol., 64, 2009, 200 http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L70020425%5Cnhttps://doi.org/10.1111/j.1398-9995.2009.02076.x.
25. Appel-da-Silva, M.C., Narvaez, G.A., Perez, L.R.R., Drehmer, L., Lewgoy, J., Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med. Mycol. Case Rep. 18 (2017), 15–17, 10.1016/j.mmcr.2017.07.007.
26. Zheng, M., Zhang, R., Tian, X., Zhou, X., Pan, X., Wong, A., Assessing the risk of probiotic dietary supplements in the context of antibiotic resistance. Front. Microbiol., 8, 2017, 10.3389/fmicb.2017.00908.
27. Nielsen, D.E., El-Sohemy, A., Applying genomics to nutrition and lifestyle modification. Per. Med. 9 (2012), 739–749, 10.2217/PME.12.79.
28. Kussmann, M., Fay, L.B., Nutrigenomics and personalized nutrition: science and concept. Per. Med. 5 (2008), 447–455, 10.2217/17410541.5.5.447.
29. Bafeta, A., Koh, M., Riveros, C., Ravaud, P., Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota. Ann. Intern. Med., 169, 2018, 240, 10.7326/M18-0343.
30. FAO/WHO, Guidelines for the Evaluation of Probiotics in Food., 2002, Food and Agriculture Organization of the United Nations and World Health Organization Group Report, London Ontario, Canada, 10.1111/j.1469-0691.2012.03873 FAO Food Nutr. Pap. 85.
31. Liong, M.T., Safety of probiotics: translocation and infection. Nutr. Rev. 66 (2008), 192–202, 10.1111/j.1753-4887.2008.00024.x.
32. Wiest, R., Garcia-Tsao, G., Bacterial translocation (BT) in cirrhosis. Hepatology. 41 (2005), 422–433, 10.1002/hep.20632.
33. Stanley, D., Mason, L.J., MacKin, K.E., Srikhanta, Y.N., Lyras, D., Prakash, M.D., Nurgali, K., Venegas, A., Hill, M.D., Moore, R.J., Wong, C.H.Y., Translocation and dissemination of commensal bacteria in post-stroke infection. Nat. Med. 22 (2016), 1277–1284, 10.1038/nm.4194.
34. Jacobi, C.A., Schulz, C., Malfertheiner, P., Treating critically ill patients with probiotics: beneficial or dangerous?. Gut Pathog., 3, 2011, 10.1186/1757-4749-3-2.
35. Kim, M.J., Ku, S., Kim, S.Y., Lee, H.H., Jin, H., Kang, S., Li, R., Johnston, T.V., Park, M.S., Ji, G.E., Safety evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI. Int. J. Mol. Sci., 19, 2018, 10.3390/ijms19051422.
36. Liu, L., Johnson, H.L., Cousens, S., Perin, J., Scott, S., Lawn, J.E., Rudan, I., Campbell, H., Cibulskis, R., Li, M., Mathers, C., Black, R.E., Child health epidemiology reference group of WHO and UNICEF, global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379 (2012), 2151–2161, 10.1016/S0140-6736(12)60560-1.
37. Zhang, G.-Q., Hu, H.-J., Liu, C.-Y., Shakya, S., Li, Z.-Y., Probiotics for preventing late-onset sepsis in preterm neonates: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore)., 95, 2016, e2581, 10.1097/MD.0000000000002581.
38. Costeloe, K., Bowler, U., Brocklehurst, P., Hardy, P., Heal, P., Juszczak, E., King, A., Panton, N., Stacey, F., Whiley, A., Wilks, M., Millar, M.R., A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: The probiotics in preterm infantS (PiPS) trial. Health Technol. Assess. (Rockv)., 20, 2016, 10.3310/hta20660 vii-83.
39. Husni, R.N., Gordon, S.M., Washington, J.A., Longworth, D.L., Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin. Infect. Dis. 25 (1997), 1048–1055 http://www.ncbi.nlm.nih.gov/pubmed/9402355.
40. Salminen, M.K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., Järvinen, A., Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin. Infect. Dis. 35 (2002), 1155–1160, 10.1086/342912.
41. Guenther, K., Straube, E., Pfister, W., Guenther, A., Huebler, A., Sever sepsis after probiotic treatment with Escherichia coli NISSLE 1917. Pediatr. Infect. Dis. J. 29 (2010), 188–189, 10.1097/INF.0b013e3181c36eb9.
42. McDonald, J.R., Acute infective endocarditis. Infect. Dis. Clin. North Am. 23 (2009), 643–664, 10.1016/j.idc.2009.04.013.
43. Cannon, J.P., Lee, T.A., Bolanos, J.T., Danziger, L.H., Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis. 24 (2005), 31–40, 10.1007/s10096-004-1253-y.
44. Yagi, S., Akaike, M., Fujimura, M., Ise, T., Yoshida, S., Sumitomo, Y., Ikeda, Y., Iwase, T., Aihara, K.I., Azuma, H., Kurushima, A., Ichikawa, Y., Kitagawa, T., Kimura, T., Nishiuchi, T., Matsumoto, T., Infective endocarditis caused by Lactobacillus. Intern. Med. 47 (2008), 1113–1116, 10.2169/internalmedicine.47.0744.
45. Encarnacion, C.O., Loranger, A.M., Bharatkumar, A.G., Almassi, G.H., Bacterial endocarditis caused by Lactobacillus acidophilus leading to rupture of sinus of Valsalva Aneurysm. Tex. Heart Inst. J. 43 (2016), 161–164, 10.14503/THIJ-15-5121.
46. Sherid, M., Samo, S., Sulaiman, S., Husein, H., Sifuentes, H., Sridhar, S., Liver abscess and bacteremia caused by Lactobacillus: Role of probiotics? Case report and review of the literature. BMC Gastroenterol., 16, 2016, 10.1186/s12876-016-0552-y.
47. Pararajasingam, A., Uwagwu, J., Lactobacillus: the not so friendly bacteria. BMJ Case Rep.(2017), 2017, 10.1136/bcr-2016-218423.
48. Doern, C.D., Nguyen, S.T., Afolabi, F., Burnham, C.A.D., Probiotic-associated aspiration pneumonia due to Lactobacillus rhamnosus. J. Clin. Microbiol. 52 (2014), 3124–3126, 10.1128/JCM.01065-14.
49. Fishman, J.A., Opportunistic infections–coming to the limits of immunosuppression?. Cold Spring Harb. Perspect. Med., 3, 2013, a015669, 10.1101/cshperspect.a015669.
50. Mo, S., Kim, B.-S., Yun, S.-J., Lee, J.-J., Yoon, S.-H., Oh, C.-H., Genome sequencing of Clostridium butyricum DKU-01, isolated from infant feces. Gut Pathog., 7, 2015, 8, 10.1186/s13099-015-0055-3.
51. Cassir, N., Benamar, S., La Scola, B., Clostridium butyricum: from beneficial to a new emerging pathogen. Clin. Microbiol. Infect. 22 (2016), 37–45, 10.1016/j.cmi.2015.10.014.
52. Huys, G., Botteldoorn, N., Delvigne, F., De Vuyst, L., Heyndrickx, M., Pot, B., Dubois, J.J., Daube, G., Microbial characterization of probiotics-Advisory report of the Working Group “8651 Probiotics” of the Belgian Superior Health Council (SHC). Mol. Nutr. Food Res. 57 (2013), 1479–1504, 10.1002/mnfr.201300065.
53. Elsner, H.A., Sobottka, I., Mack, D., Claussen, M., Laufs, R., Wirth, R., Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000), 39–42, 10.1007/s100960050007.
54. Huycke, M.M., Spiegel, C.A., Gilmore, M.S., Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 35 (1991), 1626–1634, 10.1128/AAC.35.8.1626.
55. Group, D.A.P.S., Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008), 651–659.
56. Van Baal, M.C., Kohout, P., Besselink, M.G., Van Santvoort, H.C., Benes, Z., Zazula, R., Rijkers, G.T., Gooszen, H.G., Probiotic treatment with Probioflora in patients with predicted severe acute pancreatitis without organ failure. Pancreatology, 2012, 458–462, 10.1016/j.pan.2012.08.004.
57. Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., Pettersson, S., Host-gut microbiota metabolic interactions. Science (80-.) 336 (2012), 1262–1267, 10.1126/science.1223813.
58. Spano, G., Russo, P., Lonvaud-Funel, A., Lucas, P., Alexandre, H., Grandvalet, C., Coton, E., Coton, M., Barnavon, L., Bach, B., Rattray, F., Bunte, A., Magni, C., Ladero, V., Alvarez, M., Fernández, M., Lopez, P., de Palencia, P.F., Corbi, A., Trip, H., Lolkema, J.S., Biogenic amines in fermented foods. Eur. J. Clin. Nutr. 64:Suppl. 3 (2010), S95–S100, 10.1038/ejcn.2010.218.
59. Yongsawatdigul, J., Wongngam, W., Khampirat, B., Valderrey, V., Bonasera, A., Fredrich, S., Hecht, S., Tašev, K., Ivanova-Petropulos, V., Stefova, M., Stojanović Z.S., Mehmeti, E., Kalcher, K., Guzsvány, V., Stanković D.M., YANG, S.-S., YANG, Y.-N., LI, X.-L., ZHANG, Y.B., Shalaby, A.R., Anwar, M.M., Sallam, E.M., Emam, W.H., Płotka-Wasylka, J., Simeonov, V., Namieśnik, J., Preti, R., Vieri, S., Vinci, G., Perez-Hurtado, P., Palmer, E., Owen, T., Aldcroft, C., Allen, M.H., Jones, J., Creaser, C.S., Lindley, M.R., Turner, M.A., Reynolds, J.C., Ordóñez, J.L., Callejón, R.M., Troncoso, A.M., García-Parrilla, M.C.D.C., Callejón, R.M., Nei, D., Nakamura, N., Ishihara, K., Kimura, M., Satomi, M., Manetta, A.C., Di Giuseppe, L., Tofalo, R., Martuscelli, M., Schirone, M., Giammarco, M., Suzzi, G., Mallick, S., Chandra, F., Koner, A.L., Jastrzębska, A., Kowalska, S., Szłyk, E., Jastrzebska, A., Piasta, A., Kowalska, S., Krzemiński, M., Szłyk, E., Janči, T., Valinger, D., Gajdoš Kljusurić J., Mikac, L., Vidaček, S., Ivanda, M., Henao-Escobar, W., Del Torno-De Román, L., Domínguez-Renedo, O., Alonso-Lomillo, M.A., Arcos-Martínez, M.J., Czajkowska-Mysłek, A., Leszczyńska, J., Berbegal, C., Pardo, I., Ferrer, S., Benkerroum, N., Ata, S., Akyuz, M., Cabuk, H., Albelda, J.A.V., Uzunoglu, A., Santos, G.N.C., Stanciu, L.A., Murray, A., Skene, K., Haynes, K., Griffin, M., Sobal, J., Lyson, T.A., Korhonen, J., Honkasalo, A., Seppälä J., Thi, N.B.D., Kumar, G., Lin, C.-Y., Mohammadi, M., Kamankesh, M., Hadian, Z., Mortazavian, A.M., Mohammadi, A., Parchami, R., Kamalabadi, M., Alizadeh, N., Shen, F., Wu, Q.F., Wei, Y.Q., Liu, X.M., Tang, P.A., Khairy, G.M., Azab, H.A., El-Korashy, S.A., Steiner, M.S., Duerkop, A., Sentellas, S., Nunez, O., Saurina, J., Chopra, S., Singh, A., Venugopalan, P., Singh, N., Kaur, N., Mohammed, G.I., Bashammakh, A.S., Alsibaai, A.A., Alwael, H., El-Shahawi, M.S., Hu, Y.Y., Ma, X.J., ZHANG, Y.B., Che, Y.K., Zhao, J.C., Preti, R., Vinci, G., Pinto, L., Nieto, C.H.D., Zon, M.A., Fernandez, H., de Araujo, M.C.U., Fu, Y.Q., Zhou, Z.H., Li, Y.L., Lu, X., Zhao, C.X., Xu, G.W., Dey, N., Ali, A., Podder, S., Majumdar, S., Nandi, D., Bhattacharya, S., Salazar, A.K.A., Castro, J.J.L., Cheng, W.W., Sun, D.W., Cheng, J.H., Kumar, P., Chatli, M.K., Verma, A.K., Mehta, N., Malav, O.P., Kumar, D., Sharma, N., Restuccia, D., Spizzirri, U.G., De Luca, M., Parisi, O.I., Picci, N., Chatzimitakos, T., Exarchou, V., Ordoudi, S.A., Fiamegos, Y., Stalikas, C., Aflaki, F., Ghoulipour, V., Saemian, N., Shiebani, S., Salahinejad, M., Cruz-Monterrosa, R.G., Resendiz-Cruz, V., Rayas-Amor, A.A., Lopez, M., Miranda-de La Lama, G.C., Evangelista, W.P., Silva, T.M., Guidi, L.R., Tette, P.A.S., Byrro, R.M.D., Santiago-Silva, P., Fernandes, C., Gloria, M.B.A., Bashiry, M., Mohammadi, A., Hosseini, H., Kamankesh, M., Aeenehvand, S., Mohammadi, Z., Omanovic-Miklicanin, E., Valzacchi, S., Huang, J., Gan, N., Lv, F.Y., Cao, Y.T., Ou, C.R., Tang, H.Q., Altieri, I., Semeraro, A., Scalise, F., Calderari, I., Stacchini, P., Biji, K.B., Ravishankar, C.N., Venkateswarlu, R., Mohan, C.O., Gopal, T.K.S., Preti, R., Bernacchia, R., Vinci, G., Dong, H., Xiao, K.J., Redruello, B., Ladero, V., Del Rio, B., Fernandez, M., Martin, M.C., Alvarez, M.A., Alizadeh, N., Kamalabadi, M., Mohammadi, A., Yang, D., Lu, A.X., Ren, D., Wang, J.H., Tseng, S.Y., Li, S.Y., Yi, S.Y., Sun, A.Y., Gao, D.Y., Wan, D.H., Shumilina, E., Slizyte, R., Mozuraityte, R., Dykyy, A., Stein, T.A., Dikiy, A., El-Nour, K.M.A., Salam, E.T.A., Soliman, H.M., Orabi, A.S., Ngapo, T.M., Vachon, L., Schaude, C., Meindl, C., Frohlich, E., Attard, J., Mohr, G.J., Esatbeyoglu, T., Ehmer, A., Chaize, D., Rimbach, G., Cai, Y.P., Sun, Z.W., Chen, G., Liu, X.M., You, J.M., Zhang, C.Q., Li, Z.H., Suslick, K.S., Gardini, F., Ozogul, Y., Suzzi, G., Tabanelli, G., Ozogul, F., Lin, T.R., Wu, Y.R., Li, Z.H., Song, Z.P., Guo, L.Q., Fu, F.F., Kuswandi, B., Nurfawaidi, A., Leonardo, S., Campas, M., Recent trends in the determination of biogenic amines in fermented beverages – a review. Food Chem. 26 (2016), 27–40, 10.1080/10498850.2014.964433.
60. Martin, V.T., Vij, B., Diet and headache: part 1. Headache 56 (2016), 1543–1552, 10.1111/head.12953.
61. Joosten, H.M.L.J., Northolt, M.D., Detection, growth, and amine-producing capacity of Lactobacilli in cheese. Appl. Environ. Microbiol. 55 (1989), 2356–2359.
62. Gezginc, Y., Akyol, I., Kuley, E., Özogul, F., Biogenic amines formation in Streptococcus thermophilus isolated from home-made natural yogurt. Food Chem. 138 (2013), 655–662, 10.1016/j.foodchem.2012.10.138.
63. Kuley, E., Balıkcı E., Özoğul, I., Gökdogan, S., Ozoğul, F., Stimulation of cadaverine production by foodborne pathogens in the presence of Lactobacillus, Lactococcus, and Streptococcus spp. J. Food Sci. 77 (2012), M650–M658, 10.1111/j.1750-3841.2012.02825.x.
64. Begley, M., Hill, C., Gahan, C.G.M., Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72 (2006), 1729–1738, 10.1128/AEM.72.3.1729.
65. Bustos, A.Y., Saavedra, L., de Valdez, G.F., Raya, R.R., Taranto, M.P., Relationship between bile salt hydrolase activity, changes in the internal pH and tolerance to bile acids in lactic acid bacteria. Biotechnol. Lett. 34 (2012), 1511–1518, 10.1007/s10529-012-0932-5.
66. Million, M., Angelakis, E., Paul, M., Armougom, F., Leibovici, L., Raoult, D., Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 53 (2012), 100–108, 10.1016/j.micpath.2012.05.007.
67. Rouxinol-Dias, A.L., Pinto, A.R., Janeiro, C., Rodrigues, D., Moreira, M., Dias, J., Pereira, P., Probiotics for the control of obesity - its effect on weight change. Porto Biomed. J. 1 (2016), 12–24, 10.1016/j.pbj.2016.03.005.
68. Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., Isolauri, E., Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001), 1076–1079, 10.1016/S0140-6736(00)04259-8.
69. Iemoli, E., Trabattoni, D., Parisotto, S., Borgonovo, L., Toscano, M., Rizzardini, G., Clerici, M., Ricci, E., Fusi, A., De Vecchi, E., Piconi, S., Drago, L., Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J. Clin. Gastroenterol. 46 (2012), S33–S40, 10.1097/MCG.0b013e31826a8468.
70. Kim, S.-O., Ah, Y.-M., Yu, Y.M., Choi, K.H., Shin, W.-G., Lee, J.-Y., Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Ann. Allergy Asthma Immunol. 113 (2014), 217–226, 10.1016/j.anai.2014.05.021.
71. Kopp, M., Clinical potential for the use of probiotics in the management of respiratory conditions and cold- and influenza-like symptoms. Nutr. Diet. Suppl., 51, 2011, 10.2147/NDS.S7937.
72. Taylor, A.L., Dunstan, J.A., Prescott, S.L., Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J. Allergy Clin. Immunol. 119 (2007), 184–191, 10.1016/j.jaci.2006.08.036.
73. Shida, K., Nanno, M., Nagata, S., Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2 (2011), 109–114, 10.4161/gmic.2.2.15661.
74. Marteau, P.R., De Vrese, M., Cellier, C.J., Schrezenmeir, J., Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr., 2001, 10.1093/ajcn/73.2.430s.
75. Doron, S., Snydman, D.R., Risk and safety of probiotics. Clin. Infect. Dis. 60 (2015), S129–S134, 10.1093/cid/civ085.
76. Imperial, I.C.V.J., Ibana, J.A., Addressing the antibiotic resistance problem with probiotics: reducing the risk of its double-edged sword effect. Front. Microbiol., 7, 2016, 10.3389/fmicb.2016.01983.
77. Dorman, C.J., H-NS-like nucleoid-associated proteins, mobile genetic elements and horizontal gene transfer in bacteria. Plasmid 75 (2014), 1–11, 10.1016/j.plasmid.2014.06.004.
78. Hu, Y., Yang, X., Qin, J., Lu, N., Cheng, G., Wu, N., Pan, Y., Li, J., Zhu, L., Wang, X., Meng, Z., Zhao, F., Liu, D., Ma, J., Qin, N., Xiang, C., Xiao, Y., Li, L., Yang, H., Wang, J., Yang, R., Gao, G.F., Zhu, B., Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun., 4, 2013, 2151, 10.1038/ncomms3151.
79. Aarts, H., Margolles, A., Antibiotic resistance genes in food and gut (non-pathogenic) bacteria. Bad genes in good bugs. Front. Microbiol., 5, 2014, 754, 10.3389/fmicb.2014.00754.
80. Sharma, P., Tomar, S.K., Goswami, P., Sangwan, V., Singh, R., Antibiotic resistance among commercially available probiotics. Food Res. Int. 57 (2014), 176–195, 10.1016/j.foodres.2014.01.025.
81. Abriouel, H., del C. Casado Muñoz, M., Lavilla Lerma, L., Pérez Montoro, B., Bockelmann, W., Pichner, R., Kabisch, J., Cho, G.S., Franz, C.M.A.P., Gálvez, A., Benomar, N., New insights in antibiotic resistance of Lactobacillus species from fermented foods, Food Res. Int. 78 (2015), 465–481, 10.1016/j.foodres.2015.09.016.
82. Venugopalan, V., Shriner, K.A., Wong-Beringer, A., Regulatory oversight and safety of probiotic use. Emerg. Infect. Dis. 16 (2010), 1661–1665, 10.3201/eid1611.100574.
83. Festi, D., Schiumerini, R., Eusebi, L.H., Marasco, G., Taddia, M., Colecchia, A., Gut microbiota and metabolic syndrome. World J. Gastroenterol. 20 (2014), 16079–16094, 10.3748/wjg.v20.i43.16079.
84. Giacchi, V., Sciacca, P., Betta, P., Multistrain probiotics. Probiotics, Prebiotics, and Synbiotics, 2016, 279–302, 10.1016/B978-0-12-802189-7.00019-8.
85. Patel, S., Mathivanan, N., Goyal, A., Bacterial adhesins, the pathogenic weapons to trick host defense arsenal. Biomed. Pharmacother. 93 (2017), 763–771, 10.1016/j.biopha.2017.06.102.
86. Papadimitriou, K., Zoumpopoulou, G., Foligné B., Alexandraki, V., Kazou, M., Pot, B., Tsakalidou, E., Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front. Microbiol., 6, 2015, 10.3389/fmicb.2015.00058.
87. Patel, S., Drivers of bacterial genomes plasticity and roles they play in pathogen virulence, persistence and drug resistance. Infect. Genet. Evol., 45, 2016, 10.1016/j.meegid.2016.08.030.
88. Chavarri, M., Maranon, I., Carmen, M., Encapsulation technology to protect probiotic bacteria. Int. J. Probiotics Prebiotics, 2012, 10.5772/50046.
89. Sanders, M.E., Shane, A.L., Merenstein, D.J., Advancing probiotic research in humans in the United States: challenges and strategies. Gut Microbes 7 (2016), 97–100, 10.1080/19490976.2016.1138198.
90. Olier, M., Marcq, I., Salvador-Cartier, C., Secher, T., Dobrindt, U., Boury, M., Bacquié V., Penary, M., Gaultier, E., Nougayrède, J.P., Fioramonti, J., Oswald, E., Genotoxicity of Escherichia coli NISSLE 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes 3 (2012), 501–509, 10.4161/gmic.21737.
91. Patel, S., Letter to the editor on “The necessity of overhaul in perception of microbiological culture methods”. Microb. Pathog. 102 (2017), A1–A2, 10.1016/j.micpath.2016.12.001.
92. Alfaleh, K., Anabrees, J., Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid. Based Child Heal. 9 (2014), 584–671, 10.1002/ebch.1976.
93. Lau, C.S.M., Chamberlain, R.S., Probiotic administration can prevent necrotizing enterocolitis in preterm infants: a meta-analysis. J. Pediatr. Surg. 50 (2015), 1405–1412, 10.1016/j.jpedsurg.2015.05.008.
94. Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., Zhang, T., The “golden Age” of Probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology 112 (2017), 9–23, 10.1159/000454668.
95. Barraud, D., Bollaert, P.-E., Gibot, S., Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest. 143 (2013), 646–655, 10.1378/chest.12-1745.
96. Bo, L., Li, J., Tao, T., Bai, Y., Ye, X., Hotchkiss, R.S., Kollef, M.H., Crooks, N.H., Deng, X., Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst. Rev.(2014), 2014, 10.1002/14651858.CD009066.pub2.
97. Banupriya, B., Biswal, N., Srinivasaraghavan, R., Narayanan, P., Mandal, J., Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial. Intensive Care Med. 41 (2015), 677–685, 10.1007/s00134-015-3694-4.
98. Zeng, J., Wang, C.-T., Zhang, F.-S., Qi, F., Wang, S.-F., Ma, S., Wu, T.-J., Tian, H., Tian, Z.-T., Zhang, S.-L., Qu, Y., Liu, L.-Y., Li, Y.-Z., Cui, S., Zhao, H.-L., Du, Q.-S., Ma, Z., Li, C.-H., Li, Y., Si, M., Chu, Y.-F., Meng, M., Ren, H.-S., Zhang, J.-C., Jiang, J.-J., Ding, M., Wang, Y.-P., Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Med. 42 (2016), 1018–1028, 10.1007/s00134-016-4303-x.
99. Manzanares, W., Lemieux, M., Langlois, P.L., Wischmeyer, P.E., Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit. Care, 20, 2016, 10.1186/s13054-016-1434-y.
100. Lorenzo-Zúñiga, V., Llop, E., Suárez, C., Álvarez, B., Abreu, L., Espadaler, J., Serra, J., I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J. Gastroenterol., 2014, 8709–8716, 10.3748/wjg.v20.i26.8709.
101. Didari, T., Mozaffari, S., Nikfar, S., Abdollahi, M., Effectiveness of probiotics in irritable bowel syndrome: updated systematic review with meta-analysis. World J. Gastroenterol. 21 (2015), 3072–3084, 10.3748/wjg.v21.i10.3072.
102. Lee, J.Y., Chu, S.H., Jeon, J.Y., Lee, M.K., Park, J.H., Lee, D.C., Lee, J.W., Kim, N.K., Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial. Dig. Liver Dis. 46 (2014), 1126–1132, 10.1016/j.dld.2014.09.004.
103. Redman, M.G., Ward, E.J., Phillips, R.S., The efficacy and safety of probiotics in people with cancer: a systematic review. Ann. Oncol. 25 (2014), 1919–1929, 10.1093/annonc/mdu106.
104. Carter, G.M., Esmaeili, A., Shah, H., Indyk, D., Johnson, M., Andreae, M., Sacks, H.S., Probiotics in human immunodeficiency virus infection: a systematic review and evidence synthesis of benefits and risks. Open Forum Infect. Dis., 3, 2016, 10.1093/ofid/ofw164.
105. D'Ettorre, G., Ceccarelli, G., Giustini, N., Serafino, S., Calantone, N., De Girolamo, G., Bianchi, L., Bellelli, V., Ascoli-Bartoli, T., Marcellini, S., Turriziani, O., Brenchley, J.M., Vullo, V., Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the “Probio-HIV” clinical trial. PLoS One, 10, 2015, 10.1371/journal.pone.0137200.
106. Zhang, Y., Chen, J., Wu, J., Chalson, H., Merigan, L., Mitchell, A., Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg. Nutr. 2 (2013), 142–147, 10.3978/j.issn.2304-3881.2013.06.05.
107. Sawas, T., Al Halabi, S., Hernaez, R., Carey, W.D., Cho, W.K., Patients receiving prebiotics and probiotics before liver transplantation develop fewer infections than controls: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 13 (2015), 1567–1574, 10.1016/j.cgh.2015.05.027.
108. Grąt, M., Wronka, K.M., Lewandowski, Z., Grąt, K., Krasnodębski, M., Stypułkowski, J., Hołówko, W., Masior, Ł., Kosińska, I., Wasilewicz, M., Raszeja-Wyszomirska, J., Rejowski, S., Bik, E., Patkowski, W., Krawczyk, M., Effects of continuous use of probiotics before liver transplantation: a randomized, double-blind, placebo-controlled trial. Clin. Nutr. 36 (2017), 1530–1539, 10.1016/j.clnu.2017.04.021.
109. Ammor, M.S., Belén Flórez, A., Mayo, B., Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. Food Microbiol. 24 (2007), 559–570, 10.1016/j.fm.2006.11.001.
110. Devirgiliis, C., Zinno, P., Perozzi, G., Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species. Front. Microbiol., 4, 2013, 10.3389/fmicb.2013.00301.
111. Tannock, G.W., Luchansky, J.B., Miller, L., Connell, H., Thode-Andersen, S., Mercer, A.A., Klaenhammer, T.R., Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63. Plasmid 31 (1994), 60–71, 10.1006/plas.1994.1007.
112. Kunz, A.N., Noel, J.M., Fairchok, M.P., Two Cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J. Pediatr. Gastroenterol. Nutr. 38 (2004), 457–458, 10.1097/00005176-200404000-00017.
113. Land, M.H., Rouster-Stevens, K., Woods, C.R., Cannon, M.L., Cnota, J., Shetty, A.K., Lactobacillus sepsis associated with probiotic therapy: Fig 1. Pediatrics 115 (2005), 178–181, 10.1542/peds.2004-2137.
114. De Groote, M.A., Frank, D.N., Dowell, E., Glode, M.P., Pace, N.R., Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr. Infect. Dis. J. 24 (2005), 278–280, 10.1097/01.inf.0000154588.79356.e6.
115. Vahabnezhad, E., Mochon, A.B., Wozniak, L.J., Ziring, D.A., Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J. Clin. Gastroenterol. 47 (2013), 437–439, 10.1097/MCG.0b013e318279abf0.
116. Kulkarni, H., Khoury, C., Sepsis associated with Lactobacillus bacteremia in a patient with ischemic colitis. Indian J. Crit. Care Med., 18, 2014, 606, 10.4103/0972-5229.140152.
117. Weber, E., Reynaud, Q., Suy, F., Gagneux-Brunon, A., Carricajo, A., Guillot, A., Botelho-Nevers, E., Bifidobacterium species bacteremia: risk factors in adults and infants. Clin. Infect. Dis. 61 (2015), 482–484, 10.1093/cid/civ347.
118. Bertelli, C., Pillonel, T., Torregrossa, A., Prod'hom, G., Julie Fischer, C., Greub, G., Giannoni, E., Bifidobacterium longum bacteremia in preterm infants receiving probiotics. Clin. Infect. Dis. 60 (2015), 924–927, 10.1093/cid/ciu946.
119. Zbinden, A., Zbinden, R., Berger, C., Arlettaz, R., Case series of Bifidobacterium longum bacteremia in three preterm infants on probiotic therapy. Neonatology 107 (2015), 56–59, 10.1159/000367985.
120. Avcin, S.L., Pokorn, M., Kitanovski, L., Premru, M.M., Jazbec, J., Bifidobacterium breve sepsis in child with high-risk acute lymphoblastic leukemia. Emerg. Infect. Dis. 21 (2015), 1674–1675, 10.3201/eid2109.150097.
121. Lestin, F., Pertschy, A., Rimek, D., [Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities]. [German]. Fungamie nach oraler Gabe von, Dtsch. Medizinische Wochenschrift 128 (2003), 2531–2533.
122. Atıcı S., Soysal, A., Karadeniz Cerit, K., Yılmaz, Ş., Aksu, B., Kıyan, G., Bakır, M., Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: in a child in intensive care unit and review of the literature. Med. Mycol. Case Rep. 15 (2017), 33–35, 10.1016/j.mmcr.2017.02.002.
123. Chioukh, F.Z., Ben Hmida, H., Ben Ameur, K., Toumi, A., Monastiri, K., Septicémie à Saccharomyces cerevisiae chez un prématuré traité par Ultra-Levure®. Médecine Mal. Infect. 43 (2013), 359–360, 10.1016/j.medmal.2013.06.008.
124. Shinar, E., Leitersdorf, E., Yevin, R., Lactobacillus plantarum endocarditis. Klin. Wochenschr. 62 (1984), 1173–1174, 10.1007/BF01712185.
125. Zé-Zé L., Tenreiro, R., Duarte, A., Salgado, M.J., Melo-Cristino, J., Lito, L., Carmo, M.M., Felisberto, S., Carmo, G., Case of aortic endocarditis caused by Lactobacillus casei. J. Med. Microbiol. 53 (2004), 451–453, 10.1099/jmm.0.05328-0.
126. Fradiani, P.A., Petrucca, A., Ascenzioni, F., Di Nucci, G., Teggi, A., Bilancini, S., Cipriani, P., Endocarditis caused by Lactobacillus jensenii in an immunocompetent patient. J. Med. Microbiol. 59 (2010), 607–609, 10.1099/jmm.0.017764-0.
127. Franko, B., Vaillant, M., Recule, C., Vautrin, E., Brion, J.P., Pavese, P., Lactobacillus paracasei endocarditis in a consumer of probiotics. Med. Mal. Infect. 43 (2013), 171–173, 10.1016/j.medmal.2013.01.007.
128. Boumis, E., Capone, A., Galati, V., Venditti, C., Petrosillo, N., Probiotics and infective endocarditis in patients with hereditary hemorrhagic telangiectasia: a clinical case and a review of the literature. BMC Infect. Dis., 18, 2018, 10.1186/s12879-018-2956-5.
129. Vanichanan, J., Chávez, V., Wanger, A., De Golovine, A.M., Vigil, K.J., Carbapenem-resistant Lactobacillus intra-abdominal infection in a renal transplant recipient with a history of probiotic consumption. Infection 44 (2016), 793–796, 10.1007/s15010-016-0903-1.
130. Kopp, M.V., Probiotics in the prevention and therapy of atopic diseases. Monatsschr. Kinderheilkd 156 (2008), 1084–1092, 10.1007/s00112-008-1832-6.
131. Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M., Sartor, R.B., Sherman, P.M., Mayer, E.A., An update on the use and investigation of probiotics in health and disease. Gut 62 (2013), 787–796, 10.1080/00224499.2018.1447639.